Mark,
How about one out of two?
>>Aradigm Corporation Receives Milestone Payment From Novo Nordisk for Development of AERx(R) Diabetes Management System
HAYWARD, Calif., April 5 /PRNewswire/ -- Aradigm Corporation (Nasdaq: ARDM - news) today announced that the company has received a milestone payment from Novo Nordisk (NYSE: NVO - news) in connection with completing certain clinical and product development milestones for the development of the AERx (R) Diabetes Management System. Aradigm is developing the AERx System with Novo Nordisk to deliver insulin via inhalation for patients with diabetes.
``Novo Nordisk is pleased to be involved with Aradigm in this project, as we believe Aradigm's technology is superior for the pulmonary delivery of insulin,'' said Mads Krogsgaard Thomsen, executive vice president and chief science officer at Novo Nordisk. ``This is a significant program for our company. We have completed the pre-clinical safety requirements and are preparing for the start of Phase 3 trials.''
Aradigm and Novo Nordisk are in Phase 2 clinical trials with inhaled insulin delivered using the AERx Pulmonary Delivery System. Clinical results to date confirm that pulmonary delivery using the AERx System is a reproducible method for delivering insulin to the bloodstream that is comparable to delivery via subcutaneous administration.
``This is an important accomplishment for Aradigm,'' said Richard Thompson, chairman, president and CEO of Aradigm. ``We are very excited about this program and believe that we have the right non-invasive solution for patients who need insulin. For patients with diabetes, pulmonary delivery of insulin with the AERx System may offer a quick and effective alternative that could dramatically increase their quality of life.''
Aradigm and Novo Nordisk have been collaborating on the development of the AERx Diabetes Management System since 1998. The AERx System uses liquid formulated insulin, which allows for low cost manufacturing, and includes automatic breath control that assures that patients are breathing in the correct manner with each dose of insulin.<<
Cheers, Tuck |
